SH
Satish Hanumant Deshpande
About Satish Hanumant Deshpande
Data last updated:
Satish Hanumant Deshpande has 31 years in corporate governance. Holds Designated Partner and Director roles. Currently with 22 companies, including Ssr Power Llp and La-Com Consultancy Llp. Formerly with 48 companies, such as City Multihousing Llp and Naukhal Investment Private Ltd. Engaged in General Business, Technology and more. Contributes to corporate operations. The 15 current companies with reported revenue have a combined latest revenue of ₹558 Cr; the largest is Serum Institute Life Sciences Private Limited at ₹161 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Jun 2020 | 2020 | ₹161 Cr (FY 2025) | Active | |
| Director | 28 May 2003 | 2003 | ₹142 Cr (FY 2025) | Active | |
| Director | 11 May 2005 | 2005 | ₹112 Cr (FY 2025) | Active | |
| Director | 22 Dec 2016 | 1974 | ₹85.88 Cr (FY 2019) | Active | |
| Director | 22 Feb 2016 | 1994 | ₹32.67 Cr (FY 2025) | Active | |
| Director | 26 Nov 2007 | 1974 | ₹5.54 Cr (FY 2025) | Active | |
| Director | 10 Dec 2016 | 2005 | ₹4.73 Cr (FY 2025) | Active | |
| Designated Partner | 25 Dec 2020 | 2015 | ₹4.54 Cr (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 30 Mar 2016 | 2016 | ₹51.21 Cr (FY 2023) | Active | |
| Director | 16 Jan 1995 | 1991 | ₹7.12 Cr (FY 2025) | Active | |
| Director | 19 Jan 1995 | 1990 | ₹1.66 Cr (FY 2025) | Active | |
| Director | 09 Apr 2008 | 1989 | ₹18.52 Cr (FY 2025) | Active | |
| Director | 30 Jan 2008 | 2007 | ₹2.2 Lakh (FY 2025) | Active | |
| Director | 05 Sep 2005 | 2005 | ₹2.02 Cr (FY 2024) | Active | |
| Director | 17 Jan 2006 | 2006 | – | Amalgamated | |
| Director | 17 Jan 1995 | 1991 | ₹96,000 (FY 2025) | Active | |
| Director | 16 May 2000 | 2000 | – | Converted To Llp | |
| Director | 06 Jul 2006 | 2006 | – | Converted To Llp | |
| Director | 04 Apr 2002 | 1982 | – | Converted To Llp | |
| Director | 18 Dec 1999 | 1989 | – | Amalgamated | |
| Director | 10 Jun 2003 | 2003 | – | Converted To Llp | |
| Director | 18 Nov 2014 | 2014 | – | Strike Off | |
| Director | 21 Mar 1995 | 1995 | – | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satish Hanumant Deshpande
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satish Hanumant Deshpande
Satish Hanumant Deshpande has 31 years in corporate governance. Holds Designated Partner and Director roles. Currently with 22 companies, including Ssr Power Llp and La-Com Consultancy Llp. Formerly with 48 companies, such as City Multihousing Llp and Naukhal Investment Private Ltd. Engaged in General Business, Technology and more. Contributes to corporate operations. The 15 current companies with reported revenue have a combined latest revenue of ₹558 Cr; the largest is Serum Institute Life Sciences Private Limited at ₹161 Cr (FY 2025).
Satish Hanumant Deshpande is associated with 22 companies as Designated Partner and Director, including Serum Institute Life Sciences Private Limited (₹161 Cr), Sovereign Pharma Private Limited (₹142 Cr), Poonawalla Aviation Private Limited (₹112 Cr).
Satish Hanumant Deshpande has expertise in General Business, Technology and other sectors.
Satish Hanumant Deshpande has 31 years in corporate governance.
By reported revenue, the largest current company of Satish Hanumant Deshpande is Serum Institute Life Sciences Private Limited, with revenue of ₹161 Cr (FY 2025).
The 15 current companies of Satish Hanumant Deshpande that report revenue have a combined latest revenue of ₹558 Cr.
Satish Hanumant Deshpande currently holds positions at 22 companies; the 5 largest by reported revenue are Serum Institute Life Sciences Private Limited (₹161 Cr), Sovereign Pharma Private Limited (₹142 Cr), Poonawalla Aviation Private Limited (₹112 Cr), Poonawalla Investments And Industries Private Limited (₹85.88 Cr), Adurjee & Bros Private Limited (₹32.67 Cr).